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Activation,  differentiation,  and  subsequent 
memory development of T cell are regulated by 
a complex array of TCR signals, co-stimulation, 
and inflammation (Kaech et al., 2002; Kaech 
and Wherry, 2007; Williams and Bevan, 2007). 
Although the mechanism is unclear, varied   
T cell outcomes may depend on signal intensity 
reception in individual cells (Kaech and Wherry, 
2007;  Harty  and  Badovinac,  2008).  In  parti-
cular,  there  is  emerging  and  compelling  evi-
dence that the inflammatory signals (signal 3), 
after  those  through  TCR  and  costimulatory 
molecules, are crucial in determining effector 
and memory CD8+ T cell fate. IL-12 and type   
I IFN are essential for clonal expansion, differ-
entiation of effector CD8+ T cells (Cousens et al., 
1999;  Curtsinger  et  al.,  2005;  Thompson   
et al., 2006), and memory development (Xiao 
et al., 2009). IL-2 signaling during expansion is 
also essential for development of memory CD8+ 
T cells capable of mounting full secondary ex-
pansion (Williams et al., 2006). Although these 
signals optimize CD8+ T cell responses, exces-
sive and/or prolonged exposure to inflamma-
tory signals is detrimental to generation of potent 
memory CD8+ T cells. For example, limiting 
inflammatory cues during the early expansion 
phase blunts contraction of antigen-specific 
CD8+ T cells, resulting in a massive memory 
pool (Badovinac et al., 2002, 2004). The same 
research group also established that DC immu-
nization, in the absence of overt inflammation, 
accelerates generation of antigen-specific mem-
ory CD8+ T cells (Badovinac et al., 2005; Pham 
et al., 2009). Recent advances in classification of 
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Strength of inflammatory stimuli during the early expansion phase plays a crucial role in 
the effector versus memory cell fate decision of CD8+ T cells. But it is not known how early 
lymphocyte distribution after infection has an impact on this process. We demonstrate that 
the chemokine receptor CXCR3 is involved in promoting CD8+ T cell commitment to an 
effector fate rather than a memory fate by regulating T cell recruitment to an antigen/
inflammation site. After systemic viral or bacterial infection, the contraction of CXCR3/ 
antigen-specific CD8+ T cells is significantly attenuated, resulting in massive accumulation 
of fully functional memory CD8+ T cells. Early after infection, CXCR3/ antigen-specific 
CD8+ T cells fail to cluster at the marginal zone in the spleen where inflammatory cytokines 
such as IL-12 and IFN- are abundant, thus receiving relatively weak inflammatory stimuli. 
Consequently, CXCR3/ CD8+ T cells exhibit transient expression of CD25 and preferen-
tially differentiate into memory precursor effector cells as compared with wild-type CD8+  
T cells. This series of events has important implications for development of vaccination 
strategies to generate increased numbers of antigen-specific memory CD8+ T cells via 
inhibition of CXCR3-mediated T cell migration to inflamed microenvironments.
© 2011 Kurachi et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e1606 CXCR3 and CD8+ T cell memory | Kurachi et al.
Unlike other inflammatory chemokine receptors, moreover, 
high-level  expression  of  CXCR3  is  evident  on  memory 
CD8+ T cells even after resolution of the inflammatory re-
sponse and could be used as a marker to predict recall efficacy 
of memory CD8+ T cells (Hikono et al., 2007; Kohlmeier   
et al., 2008). Interestingly, differential expression of CXCR3 
is critically associated with functional capacity of memory 
CD8+ T cells. CXCR3lo memory CD8+ T cells have a highly 
activated phenotype and decline in number over time, whereas 
CXCR3hi memory CD8+ T cells have a resting (stable) pheno-
type and become a predominant population at a later stage 
(Hikono et al., 2007). In addition, expression of CXCR3 
gradually decreases when CD8+ T cells are exhausted during 
chronic lymphocytic choriomeningitis virus infection or ex-
perience multiple rounds of antigen challenge (Wherry et al., 
2007; Wirth et al., 2010). How CXCR3 influences differenti-
ation of the antigen-specific memory CD8+ T cells is there-
fore of great interest. Using TCR transgenic CD8+ T cells 
lacking CXCR3 and models of acute systemic viral and bac-
terial infection, we show that CXCR3-mediated micro-
distribution of CD8+ T cells in spleen (priming site) controls 
strength of inflammatory stimuli received by CD8+ T cells 
during the early expansion phase, thereby regulating effector/
memory balance.
RESULTS
Attenuated contraction of CXCR3/ antigen-specific CD8+ 
T cells in response to infection
It is known that effector CD8+ T cells up-regulate a variety 
of chemokine receptors to track inflammation. Although 
expression of these receptors, such as CCR5, is transient, 
CXCR3 is known to be continuously expressed on antigen-
experienced CD8+ T cells even in the steady-state memory 
phase (Hikono et al., 2007; Kohlmeier et al., 2008). In fact, 
after systemic infection with recombinant vaccinia virus 
expressing OVA (VV-OVA), antigen-specific CD8+ T cells 
uniformly express CXCR3 at day 7, and high-level CXCR3 
expression on memory CD8+ T cells is evident at least 70 d 
later (Fig. 1 A). This raises an important question. How do 
antigen-specific memory CD8+ T cells form in the absence of 
CXCR3? To answer this, we used a dual adoptive transfer ap-
proach in which CXCR3 was absent solely in one popula-
tion of donor OT-I cells (Fig. 1 B). Recipient mice (CD45.1+) 
received a 1:1 mixture of naive CXCR3/ (CD45.2+) and 
WT (CD45.1+ CD45.2+) OT-I cells and were then infected 
with VV-OVA. Both CXCR3/ and WT OT-I input cells 
showed similar naive phenotypes and distributed in the same 
manner after adoptive transfer (Fig. S1). As shown in Fig. 1   
(C and D), robust expansion of CXCR3/ OT-I cells was 
observed during the acute phase of infection (until day 7) and 
was indistinguishable from that of the WT OT-I cells. Sur-
prisingly, after peak of expansion CXCR3/ OT-I cells 
showed  significantly  attenuated  contraction,  whereas WT 
OT-I cells declined ordinarily, resulting in CXCR3/ OT-I 
cells predominating in the antigen-specific memory CD8+  
T cell population at the later time points (Fig. 1, C and D). 
effector CD8+ T cell subpopulations suggest how early in-
flammatory stimuli influence relative frequency of effector-   
or memory-fated cells. Based on expression of CD127 and 
KLRG1, effector CD8+ T cells can be divided into at least 
two  major  subsets:  (1)  terminally  differentiated  short-lived   
effector cells (SLECs; CD127lo KLRG1hi); and (2) memory pre-
cursor effector cells (MPECs; CD127hi KLRG1lo; Joshi et al., 
2007). Increased IL-12 and IL-2 signaling on activation accel-
erates differentiation of CD8+ T cells toward SLECs to com-
pensate for diminished effector CD8+ T cell conversion to 
memory cells (Joshi et al., 2007; Kalia et al., 2010; Pipkin   
et al., 2010). This inflammatory stimuli-mediated effector cell 
commitment into SLEC fate in the early expansion phase is 
regulated by transcription factor expression. IL-12 promotes 
CD8+ T cell expression of T-bet and represses Eomes in a 
dose-dependent manner, leading to greater SLEC frequency 
(Takemoto et al., 2006; Joshi et al., 2007; Rutishauser and 
Kaech, 2010). Another pair of transcription factors, Blimp-1 
and Bcl-6, are also involved in this process; CD8+ T cells   
capable of receiving prolonged IL-2 signals (CD25hi cells) ex-
press higher levels of Blimp-1 (Kalia et al., 2010), whereas 
MPECs express higher levels of Bcl-6, a key negative regula-
tor of Blimp-1 (Kallies et al., 2009; Rutishauser et al., 2009; 
Crotty et al., 2010). These findings suggest that effector and 
memory CD8+ T cell fate decisions are largely dictated by in-
flammatory signal strength during the early expansion phase 
(Harty  and  Badovinac,  2008).  But  how  the  inflammatory 
stimuli-mediated CD8+ T cell developmental program is in-
fluenced by the anatomical microenvironment and what fac-
tors determine early phase distribution of antigen-specific 
CD8+ T cells in lymphoid tissues are unknown.
In general, T cell migration to inflammation site is gov-
erned in a complex manner by surface expression of chemo-
kine receptors and specific ligands (Bromley et al., 2008). 
CXCR3,  a  receptor  for  the  inflammatory  chemokines 
CXCL9/Mig,  CXCL10/IP-10,  and  CXCL11/I-TAC,  is 
preferentially expressed on activated CD8+ T cells in addition 
to Th1 cells and is thought to play an important role in traf-
ficking to inflammation site (Hancock et al., 2000; Liu et al., 
2005). In fact, CXCR3/ effector CD8+ T cells show a sig-
nificant defect in migrating from peripheral blood to inflamed 
nonlymphoid  tissues  such  as  lung,  liver,  brain,  and  vagina 
(Hokeness et al., 2007; Fadel et al., 2008; Zhang et al., 2008; 
Nakanishi et al., 2009). In addition to chemotaxis, CXCR3 
signaling may influence development of effector T cells 
because CD8+ T cells in receptor- or ligand-knockout mice 
have reduced proliferative and cytotoxic ability (Dufour et al., 
2002; Whiting et al., 2004; Thapa and Carr, 2009; Rosenblum 
et al., 2010). Although bystander effects, caused by overall de-
ficiency of CXCR3 or its ligands in vivo, at the level of in-
flammatory response, should be considered as part of these 
studies, it is also known that stimulation of CXCR3 could 
induce phosphorylation of TCR signaling molecules and as-
sociation of CXCR3 and CD3 subunit on the T cell surface 
(Dar and Knechtle, 2007; Newton et al., 2009), indicating   
a potential role of CXCR3 for a costimulatory molecule. JEM Vol. 208, No. 8 
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Increased frequency of splenic CXCR3/ OT-I cells was 
not a result of the inability to migrate to nonlymphoid tissues 
because CXCR3/ OT-I cells predominated in all lymphoid 
and nonlymphoid tissues in the memory phase (Fig. 1 E). 
Attenuated contraction of CXCR3/ OT-I was not unique 
to vaccinia virus infection because increased frequency of 
CXCR3/ memory OT-I cells was also observed after in-
fection  with  recombinant  Listeria  monocytogenes  expressing 
OVA (LM-OVA), both in dual and single adoptive transfer 
approaches (Fig. S2, A–D). Furthermore, to exclude potential 
impact of high precursor frequency on subsequent genera-
tions of antigen-specific memory CD8+ T cells, we made 
mixed BM chimera in which irradiated C57BL/6 (B6) mice 
were reconstituted with BM from WT B6 mice and CXCR3-
deficient donors (Fig. S2 E). As anticipated, after infection 
both  populations  of  OVA257-264-specific  CD8+ T  cells  ex-
panded, at the same rate, to day 8, followed by sustained 
numbers of antigen-specific memory CD8+ T cells lacking 
CXCR3 (Fig. S2, F and G). This supports our observation 
that CXCR3/ CD8+ T cells have preferential ability to 
form a memory CD8+ T cell pool. Furthermore, using the 
same dual adoptive transfer approach we observed no difference 
in frequencies of CCR5/ and WT OT-I cells throughout 
the response (Fig. S3), indicating that attenuated contraction 
of antigen-specific CD8+ T cells is unique to cells lacking 
CXCR3, not CCR5. Altogether, we conclude that memory 
CD8+ T cell formation in response to infection is significantly 
facilitated by absence of CXCR3.
CXCR3/ and WT memory CD8+ T cells show similar 
functional properties
Given the relative dominance of the CXCR3/ memory 
CD8+ T cell population compared with its WT counterpart, 
it is useful to compare their functional characteristics as po-
tent providers of immune protection. Using the same dual 
adoptive transfer approach, we first evaluated their abilities 
to produce effector cytokines upon in vitro restimulation. 
As shown in Fig. 2 A, both memory OT-I cells had a similar 
ability to produce IFN- and TNF. However, the fraction of 
IFN-+ cells that produced IL-2 in CXCR3/ OT-I cells 
was higher than that in WT OT-I cells (Fig. 2, A and B). There 
appears to be an inverse correlation between activation status 
and ability of CD8+ T cells to produce IL-2, such that cells 
with the rested (naive or memory) phenotype have superior 
ability to produce IL-2 in response to antigenic stimulation 
(Kaech et al., 2003; Wherry et al., 2003; Marzo et al., 2005; 
Intlekofer et al., 2007; Joshi et al., 2007; Sarkar et al., 2008). 
Consequently, WT OT-I cells may exhibit the characteris-
tics of memory cells with highly activated status relative to 
CXCR3/ OT-I cells. Increased expression of granzyme   
B  protein  in WT  OT-I  cells  compared  with  CXCR3/  
OT-I cells also supports this hypothesis (Fig. 2 C).
Next, we compared their abilities to mount recall response 
on rechallenge. More than 40 d after infection, CD8+ enriched 
spleen cells containing equivalent numbers of CXCR3/ 
and WT OT-I cells were labeled with CFSE and transferred 
Figure 1.  An increased number of CXCR3/ memory CD8+ T cells 
is observed in lymphoid and nonlymphoid organs. (A) Expression ki-
netics of CXCR3 on antigen-specific CD8+ T cells in peripheral blood at 
the indicated times after VV-OVA infection. Representative histograms 
gated on CD8+ T cells, CD44mid, and CD62Llo before infection and  
Kb-OVA257–tetramer+ after infection. Numbers on the plot indicate the 
percentage positive for CXCR3. Black line: CXCR3; shaded: isotype control. 
(B) Naive splenic CXCR3/ (CD45.2+) and WT (CD45.1+CD45.2+) OT-I cells 
were mixed in a 1:1 ratio, and a total of 1 × 104 cells were adoptively 
transferred into naive CD45.1+ mice. The next day, the recipient mice 
were i.v. infected with 2 × 106 PFU VV-OVA. Flow plot shows representa-
tive mixed OT-I cells before transfer. (C) Representative plots gated on 
OT-I cells (CD45.2+) in the spleen at the indicated times after infection. 
Numbers on the plots indicate the percentage of WT (top) and CXCR3/ 
(bottom) OT-I cells in the total OT-I population. (D) Number of OT-I cells 
in the spleen after VV-OVA infection. Data are shown as mean ± SEM.  
(E) Number of OT-I cells in blood, liver, lung, spleen, and lymph nodes on 
day 7 (left) and day 225 (right) after infection. OT-I cells in blood are 
plotted per 1 × 107 cells. Data are shown as mean ± SEM. *, P < 0.05. 
Data represent two (A) or three (B–E) independent experiments (n = 4–5 
and 3–4 per time point, respectively).1608 CXCR3 and CD8+ T cell memory | Kurachi et al.
similar ability to kill specific target cells in vivo (Fig. 2 F). After 
LM-OVA  challenge,  moreover,  both  CXCR3/  and WT 
memory OT-I cells conferred equivalent protective immunity 
on a per-cell basis (Fig. 2 G). These results demonstrate that, de-
spite slightly different cytokine profiles, both memory popula-
tions differentiate into equally potent killer cells after reactivation 
and confer similar protective immunity on a per-cell basis.
into recipient mice (Fig. 2 D). 1 d later, recipient mice were in-
fected with  VV-OVA. As shown in Fig. 2 E, there were no differ-
ences in early proliferation and secondary expansion between 
CXCR3/ and WT memory OT-I cells. To further investigate 
their abilities to confer protective immunity, we performed in 
vivo killing assay and found that, consistent with the previous 
findings, CXCR3/ and WT memory OT-I cells exhibited 
Figure 2.  CXCR3/ memory CD8+ T cells exhibit similar functional capacities to WT cells. (A–C) Mixed CXCR3/ and WT OT-I cells were trans-
ferred, followed by VV-OVA infection as in Fig.1 B. Cytokine production and granzyme B expression by CXCR3/ and WT memory OT-I cells was analyzed at 
day 43 after infection. (A) Representative flow cytometry plots showing TNF, IL-2, and IFN- production. (B) Number of IFN-+ IL-2+ OT-I cells in the spleen. 
Data are shown as mean ± SEM. *, P < 0.01. (C) Granzyme B expression. Numbers below the granzyme B plots show mean fluorescence intensity (MFI).  
(D) CXCR3/ or WT memory OT-I cells were generated in separate hosts and isolated from spleen at day 40+ after infection. CXCR3/ and WT memory 
OT-I cells were CFSE labeled or not and adoptively transferred in a 1:1 mixture (1.9 × 106 cells total). (E) Recipient mice were rechallenged with VV-OVA 1 d 
after transfer. Representative plots showing proliferation of both OT-I cells on day 3 after infection as determined by CFSE dilution. Data are shown as mean ± 
SEM. (F) 1 d after transfer of unlabeled CXCR3/ or WT memory OT-I cells, OVA peptide–pulsed (CFSEhi) and unpulsed (CFSElo) target cells were injected 
and killing was assessed 4 h later. Data are shown as mean ± SEM. (G) 1 d after transfer of unlabeled memory OT-I cells, recipient mice were challenged  
i.v. with 1 × 106 CFU LM-OVA. Bacterial numbers in the spleen were determined 3 d after challenge. Bars represent mean. *, P < 0.001; **, P < 0.005. Data repre-
sent three (A–C) or two (D–G) independent experiments (n = 3–4 per time point). (H and I) 1 × 104 naive splenic CXCR3/ or WT OT-I cells were transferred 
into separate CD45.1 WT recipients, followed by i.v. infection with 2 × 106 PFU VV-OVA. After day 30+, the recipient mice were challenged i.v. with 1 × 107 
CFU LM-OVA. Data represent two independent experiments (n = 4–6 per group). (H) Flow cytometry plots show the frequency of CXCR3/ or WT OT-I cells 
in PBMC 1 d before LM-OVA challenge. (I) Bacterial titers in the spleen at 3 d after challenge. Bars represent mean. *, P < 0.05.JEM Vol. 208, No. 8 
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difference in BrdU incorporation between CXCR3/ and 
WT memory CD8+ T cells (Fig. 3 E). Transferring CFSE-
labeled memory OT-I cells into naive mice without irradia-
tion also confirmed this finding. 17 d later, the division profiles 
of CXCR3/ and WT memory CD8+ T cells revealed that 
Given that the number of memory CXCR3/ CD8+ 
cells surpassed that of WT cells, we propose that increased 
generation of memory CD8+ T cells by CXCR3 inhibition 
during initial immunization would confer superior protec-
tion at the whole-body level upon subsequent infection. To 
test this idea, we rechallenged CXCR3/ and WT mice 
with  LM-OVA,  which  had  been  immunized  by VV-OVA 
(Fig. S4). As shown in Fig. S4 B, consistent with the results 
described in Fig. 1 and Fig. S2, CXCR3/ mice exhibited 
an increased number of antigen-specific memory CD8+ T cells. 
Importantly, compared with WT mice, these CXCR3/  
mice showed reduced bacterial burden after rechallenge   
(Fig. S4 C). To exclude the possibility that global CXCR3 
deficiency might affect protection as a result of alteration of the 
overall inflammatory or immune response during rechallenge, 
we also examined pathogen titers in OT-I single-transferred 
mice in which CXCR3 deficiency is limited to antigen-
specific CD8+ T cells (Fig. 2, H–I). Consistent with observa-
tions in CXCR3/ mice, the mice containing an increased 
number of CXCR3/ memory OT-I cells showed enhanced 
protective immunity compared with WT memory OT-I cells. 
Collectively, these results suggest that CXCR3 blockade dur-
ing immunization might be a useful strategy for improving 
the vaccine efficacy.
CXCR3/ and WT memory CD8+ T cells show similar 
proliferative ability
Next, we addressed how massive memory CD8+ T cells form 
when T cells lack surface expression of CXCR3. First, by 
conducting tetramer binding assay and checking functional 
avidity, we excluded the possibility that altered differentiation 
of CXCR3/ memory cells is a result of different TCR ex-
pression or TCR signaling between CXCR3/ and WT 
cells (Slifka and Whitton, 2001). We found that CXCR3/ 
OT-I cells express a similar level of TCR and produce a similar 
amount of IFN- with diluted concentration of cognate 
peptide  stimulation  (Fig.  S5). We  next  hypothesized  that 
CXCR3/ memory CD8+ T cells have superior capacity to 
persist long term in vivo and undergo higher homeostatic 
proliferation compared with WT memory CD8+ T cells. To 
test this, we first compared the phenotypes of CXCR3/ 
and WT memory CD8+ T cells. As expected, CXCR3/ 
memory OT-I cells contained more CD62Lhi CCR7hi cen-
tral memory cells (Fig. 3 A). Moreover, as shown in Fig. 3   
(B–D), CXCR3/ memory CD8+ T cells also showed the 
characteristics of high memory potential compared with their 
WT counterparts, as determined by expression of CD127, 
KLRG1,  CD27,  and  CD122  (Kaech  and Wherry,  2007;   
Williams and Bevan, 2007; Rutishauser and Kaech, 2010), 
which is consistent with their cytokine profile upon restimu-
lation (Fig. 2, A–C). These findings suggest that the skewed 
ratio of CXCR3/ to  WT memory CD8+  T cells may be a conse-
quence of superior homeostatic proliferation of CXCR3/ 
memory CD8+ T cells. To investigate this, mice were given 
BrdU during the memory phase, and frequency of BrdU+ 
cells was then compared. We were surprised to observe no 
Figure 3.  CXCR3/ memory CD8+ T cells display a high memory 
potential phenotype. (A–D) 1 d after transfer of mixed CXCR3/ and 
WT OT-I cells, recipient mice were infected with VV-OVA as in Fig.1 B.  
(A and B) Surface expression of indicated markers on CXCR3/ and WT 
OT-I cells in the spleen was analyzed on day 99 after infection. (C) Num-
bers of CD127hi KLRG1lo cells in the spleen at day 99 are shown as mean ± 
SEM. *, P < 0.05. (D) Expression of CD27 and CD122 on splenic OT-I cells 
at the same time point. Numbers to the right of the CD122 plots indicate 
the MFI and MFI ratio of CXCR3/ to WT. (E) 70+ d after transfer, the 
recipient mice containing both CXCR3/ and WT memory OT-I cells were 
administered BrdU for 17 d. (F and G) CXCR3/ and WT memory OT-I 
cells were generated in separate hosts as shown in Fig. 2 D. On day 40+ 
after infection, OT-I cells were isolated from spleen, labeled with CFSE, 
and co-transferred into naive nonirradiated recipient mice. (F) Homeo-
static proliferation was determined by CFSE dilution 17 d after transfer. 
Histograms gated on OT-I cells show the ratio of CXCR3/ and WT OT-I 
cells at transfer (day 0) and day 17 after transfer, and CFSE dilution.  
(G) Number of OT-I cells in spleen. Data are shown as mean ± SEM. Data 
represent three (A–D) or two (E–G) independent experiments (n = 3–4).1610 CXCR3 and CD8+ T cell memory | Kurachi et al.
WT effector CD8+ T cells until day 5 
after infection. Around the peak of 
expansion,  however,  increased  frequencies  of  BrdU+  cells 
were still observed in WT effector CD8+ T cells, whereas 
those in the CXCR3/ effector CD8+ T cells decreased sig-
nificantly (Fig. 4, A and B). This seems to contradict observa-
tion of preferential accumulation of CXCR3/ memory 
CD8+ T cells compared with WT counterparts. It should be 
noted that numbers of CXCR3/ and WT CD8+ T cells 
were indistinguishable until peak of expansion (Fig. 1 D). Be-
cause T cell accumulation results from a combination of cell 
death and proliferation, we hypothesized that CXCR3/  
effector CD8+ T cells survive better than WT effector CD8+  
T cells at the peak of expansion as a result of small differences 
in number of effector CD8+ T cells in the two groups. As anti-
cipated,  there  was  more  apoptosis  in WT  compared  with 
CXCR3/ effector CD8+ T cells as determined by expres-
sion of Bcl-2 and annexin V at day 7 (Fig. 4 C). A higher fre-
quency of apoptosis in WT effector CD8+ T cells was also 
confirmed by caspase activity and TUNEL assays (Fig. 4,   
D and E). To precisely compare contraction of CXCR3/ 
and WT CD8+ T cells, equal numbers of both effector OT-I 
both cells had undergone similar division (Fig. 3 F). In addi-
tion, both memory OT-I cells showed similar redistribution 
and survival after transfer (Fig. 3, F and G; and unpublished 
data). Collectively, these data demonstrate that, despite pheno-
typic differences between CXCR3/ and WT cells, the   
sustained  numbers  of  CXCR3/  memory  CD8+ T  cells 
cannot be explained by their rates of homeostatic prolif-
eration or their homing properties during the steady-state 
memory phase.
CXCR3/ CD8+ T cells primed in vivo are preferentially 
committed to become antiapoptotic and MPECs
Thus far, the data suggest that earlier events on CD8+ T cell 
differentiation, after infection, may be the key to determining 
different amounts of memory formation. Therefore, we ex-
tended the BrdU approach, in which the proliferative re-
sponses of CXCR3/ and WT effector CD8+ T cells in the 
24 h preceding sacrifice were measured during the early phase 
of infection. As shown in Fig. 4 (A and B), we observed con-
sistent increases in BrdU incorporation for CXCR3/ and 
Figure 4.  CXCR3/ effector CD8+  
T cells show resistance to cell death in the 
late effector phase. (A–E) 1 d after transfer 
of mixed CXCR3/ and WT OT-I cells, recipi-
ent mice were infected with VV-OVA as in 
Fig.1 B. (A) Recipient mice were i.p. injected 
with BrdU 24 h before sacrifice. Representa-
tive histograms gated on CXCR3/ or WT 
OT-I cells in the spleen show BrdU incorpo-
ration. Numbers indicate the percentage of 
BrdU-positive population. (B) Ratio of per-
centage of BrdU-positive population of 
CXCR3/ to WT OT-I cells. Data are shown 
as mean ± SEM. *, P < 0.001; **, P < 0.0001. 
(C–E) Apoptotic balance of CXCR3/ and 
WT OT-I cells at days 5 and 7 after infection 
was evaluated by measuring percentage of 
Bcl-2+ and annexin V+ cells (C), pan-caspase 
activity (D), and TUNEL assay (E). Data are 
shown as mean ± SEM. *, P < 0.05.  
(F) CXCR3/ and WT effector OT-I cells were 
generated in separate hosts and recovered 
from the spleen on day 6 after VV-OVA in-
fection. A 1:1 mixture of CXCR3/ and WT 
OT-I cells was transferred into naive hosts 
and contraction of both OT-I cell popula-
tions was compared. (G) Representative 
plots showing the percentage of CXCR3/ 
(bottom) and WT (top) cells out of the total 
OT-I populations at days 1 and 41 after 
transfer. (H) Number of OT-I cells at days 1 
and 41 after transfer. Data are shown as 
mean ± SEM. *, P < 0.05. Data represent 
three (A–C) or two (D–H) independent ex-
periments (n = 3–4 per time point).JEM Vol. 208, No. 8 
Article
1611
comparison with their WT counterparts, are more committed to 
becoming long-lived memory cells. This would also account for 
their attenuated contraction. To test this idea, we first compared 
the phenotype of CXCR3/ and WT effector CD8+ T cells. 
At day 7 after infection, CXCR3/ effector CD8+ T cells con-
tained a higher frequency of CD127hi KLRG1lo CD27hi MPECs 
and a lower frequency of CD127lo KLRG1hi CD27lo SLECs, in 
comparison with their WT counterparts (Fig. 5, A–C). Predomi-
nant differentiation of CXCR3/ cells into MPECs was also 
true for all lymphoid and nonlymphoid tissues determined (un-
published data). In addition to their phenotype, CXCR3/  
effector  CD8+  T  cells  also  exhibited  various  functional 
characteristics as MPECs, such as superior IL-2 but inferior 
granzyme B production compared with WT effector CD8+  
T cells (Fig. 5, D and E). This suggests that CD8+ T cells, primed 
in the absence of CXCR3 in vivo, are programmed to become 
MPECs and have preferential longevity.
cell types, primed in vivo, were transferred into the same re-
cipient mice (Fig. 4, F–H). Consistent with previous results 
(Fig. 1 and Figs. S2–S4), CXCR3/ effector cells exhibited 
more  memory  generation. These  results  indicate  that  the 
CXCR3/ effector CD8+ T cells proliferate well in the early 
expansion phase, but their proliferation later decreases and 
they are more resistant to apoptosis.
It is known that the effector CD8+ T cell population can 
be subdivided into SLEC and MPEC populations; CD127lo 
KLRG1hi SLECs are considered more terminally differenti-
ated  with  reduced  longevity,  whereas  CD127hi  KLRG1lo 
MPECs have a preferential ability to differentiate into a long-
lived memory population (Joshi et al., 2007; Kaech and 
Wherry, 2007). It is also shown that SLECs divide longer than 
MPECs, and cells that continue to proliferate during late ex-
pansion contribute less to long-lived memory lineage (Sarkar 
et al., 2008). If this is so, CXCR3/ effector CD8+ T cells, in 
Figure 5.  CXCR3 deficiency alters effector CD8+ T cell phenotype to MPECs in vivo. (A–E) 1 d after transfer of mixed CXCR3/ and WT OT-I cells, 
recipient mice were infected with VV-OVA as in Fig.1 B. OT-I cells in spleen were analyzed at day 7 after infection. Data represent three independent ex-
periments (n = 3–4 per time point). (A) Expression of CD127 and KLRG1. (B) Percentage of CD127hi KLRG1lo cells among OT-I cells. Bars represent mean.  
*, P < 0.0001. (C) Expression of CD27 and CD122. Numbers to the right of CD122 plots show MFI and MFI ratio of CXCR3/ to WT. (D) Intracellular gran-
zyme B expression. Numbers below granzyme B plots indicate MFI. (E) Intracellular TNF, IL-2, and IFN- production. (F) Naive CXCR3/ and WT OT-I cells 
(mixed in a 1:1 ratio) were co-cultured with DC-OVA in the presence or absence of CXCR3 ligands (CXCL9, CXCL10, or CXCL11) for 7 d. (G) Phenotype and 
cytokine production profiles of OT-I cells on day 7. Representative data at 100 ng/ml ligand stimulation. (H and I) Cultured OT-I cells were transferred into 
WT mice. (H) Percentage of CXCR3/ (bottom) and WT (top) cells in total OT-I populations at days 1 and 42 after transfer. (I) Number of in vitro–generated 
CTL at days 1 and 42 after transfer. Data are shown as mean ± SEM. (F–I) Data are representative of two independent experiments (n = 3).1612 CXCR3 and CD8+ T cell memory | Kurachi et al.
of CXCR3 on effector CD8+ T cell fate 
decision is only observed when cells are 
primed  in  vivo. We  also  confirmed  that 
skewed MPEC commitment is not a result 
of  absence  of  intrinsic  signals  through 
CXCR3 on CD8+ T cells because addition 
of CXCR3 ligands during proliferation 
in vitro had no impact on the phenotype 
characteristics of effector CD8+ T cells 
(Fig. 5 G and unpublished data). Moreover, when we trans-
ferred in vitro–primed day-7 effector cells, CXCR3/ OT-I 
cells now contracted at the same rate as WT OT-I cells in vivo 
(Fig. 5, H and I). Collectively, these results provide conclusive 
evidence that CXCR3 does alter effector CD8+ T cell fate 
decision; CD8+ T cells, primed in the absence of CXCR3 in 
vivo, are preferentially differentiated into MPECs, leading to 
the blunted contraction of effector CD8+ T cells.
Shortened expression of CD25 on CXCR3/ CD8+ T cells
Previous studies demonstrate that strength and duration of 
inflammatory signals during the early expansion phase have a 
profound  impact  not  only  on  divergent  differentiation  of   
effector subpopulations but also on the extent of CD8+ T cell 
contraction (Badovinac et al., 2004; Joshi et al., 2007; Harty 
and Badovinac, 2008). Of these signals, IL-2 is recently re-
ported to play a major role in effector CD8+ T cell fate deci-
sion. Prolonged IL-2 signals and expression of CD25 (IL-2R) 
during the early expansion phase critically correlate with dif-
ferentiation of CD8+ T cells into SLECs (Kalia et al., 2010; 
Pipkin et al., 2010). We next examined very early events in 
CD8+ T  cell  responses,  including  timing  and  duration  of 
CD25 expression on CD8+ T cells in vivo. 24 h after infec-
tion, both CXCR3/ and WT OT-I cells displayed uni-
formly high expression of CD25 and CD69, indicating that 
Recent research suggests that differential exposure to cyto-
kines, including IL-2 and IL-12, during the early expansion 
phase alters cell fate decisions affecting SLEC or MPEC lin-
eage (Joshi et al., 2007; Cui et al., 2009; Kalia et al., 2010; 
Pipkin et al., 2010). Because CXCR3 promotes lymphocyte 
migration to focus of inflammation, and CXCR3 deficiency 
is exclusively limited to one population of antigen-specific 
CD8+ T cells in our experiments, it is reasonable to suggest 
that CXCR3/ and WT CD8 T cells receive, quantitatively 
or qualitatively, different inflammatory signals and/or antigen 
presentation during the early expansion phase. It has been 
shown that CXCR3 might play a role as a costimulatory 
molecule. So it is possible that preferential differentiation of 
WT CD8+ T cells into SLECs is a result of the intrinsic effect 
of CXCR3 signaling. To test this, we then examined whether 
priming and subsequent proliferation of both CD8+ T cells 
in the same condition in vitro (without CXCR3-directed 
migration in vivo) would have an impact on their differen-
tiation. Naive CXCR3/ and WT OT-I cells were mixed 
together and stimulated in vitro with mature DCs loaded 
with OVA peptide (DC-OVA; Fig. 5 F). Strikingly, at day 7, in 
contrast to Fig. 5 A, we observed no differences in frequency 
of effector CD8+ T cell subpopulation (MPECs vs. SLECs 
and percentage of IL-2+ IFN-+) between CXCR3/ and 
WT effector OT-I cells (Fig. 5 G). This indicates that impact 
Figure 6.  CXCR3/ effector CD8+ T cells ex-
hibit shortened activation phenotype. (A–C) 1 d 
after transfer of mixed CXCR3/ and WT OT-I cells 
(total 1–3 × 106 cells), recipient mice were in-
fected with VV-OVA as in Fig.1 B. (A) Surface ex-
pression of CD25 and CD69 and forward scatter 
(FSC) at the indicated times after infection. (B) Cell 
division (CFSE) and CXCR3 expression at indicated 
times after infection. (C) MFI of CD25 staining on 
OT-I cells at indicated times after infection. Data 
are shown as mean ± SEM. *, P < 0.0001; **, P < 
0.005. (D) Relative Prdm1 mRNA expression in OT-I 
cells was measured by quantitative RT-PCR at day 7 
after infection. All data represent two independent 
experiments (n = 4 independent samples per time 
point) and are shown as mean ± SEM. *, P < 0.0001. 
(E) Mixed OT-I cells were stimulated by anti-CD3 
and anti-CD28 antibodies, cultured in the presence 
and absence of CXCL9, CXCL10, and CXCL11 for 3 d, 
and stained for CD25. Representative histograms at 
100 ng/ml CXCR3 ligand stimulation from two in-
dependent experiments are shown.JEM Vol. 208, No. 8 
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compared with WT CD8+ T cells, 
and this leads to shortened expres-
sion of CD25 during early expansion 
followed by enhanced differentiation 
into MPECs.
Failure of acute cluster formation by CXCR3/ CD8+ T cells
It is interesting that CXCR3/ and WT CD8+ T cells ex-
hibit differential activation as early as day 2 after infection, 
whereas both cells may acquire equivalent priming signals 
after infection because they both distribute in a similar way 
before infection (Fig. S1, B and C). Given that CXCR3 is 
expressed on almost all WT cells by this time (Fig. 6 B), 
CXCR3-dependent migration can account for these differ-
ences. Thus, we next investigated whether lack of surface ex-
pression  of  CXCR3  alters  localization  of  antigen-specific 
CD8+ T cells after infection in spleen, a primary organ which 
initiates CD8+ T cell response after systemic infection with 
VV-OVA. Previous studies have shown that after systemic in-
fection with LM-OVA, initial activation of antigen-specific 
CD8+ T cells in the spleen occurs at the borders of the B and 
T cell zones and in the marginal zones (MZs), followed by 
clear-cut formation of clusters with antigen-presenting cells 
(Khanna et al., 2007). After activation and proliferation, CD8+ 
T  cells  exit  to  the  red  pulp  (RP)  via  bridging  channels 
(Khanna et al., 2007). In the case of VV-OVA infection, both 
CXCR3/ and WT CD8+ T cells were localized to T cell 
the majority of cells were already activated (Fig. 6 A). It is   
important to note that a large fraction of WT OT-I cells 
strongly expressed CXCR3 at this point, even before cell di-
vision, suggesting a potential impact for this chemokine re-
ceptor on early CD8+ T cell responses (Fig. 6 B). By 48–72 h, 
when cells started division, CXCR3/ OT-I cells down-
regulated  CD25  and  CD69  much  faster  than WT  cells   
(Fig. 6, A and C). Along with CD25 and CD69 expression, 
CXCR3/ OT-I cells showed reduced blastogenic response 
compared with WT cells (Fig. 6 A). Shortened expression of 
CD25 resulted in decreased Blimp-1 expression at later time 
points, indicating a decreased susceptibility of CXCR3/ 
cells to IL-2 signaling (Fig. 6 D; Kalia et al., 2010). We consid-
ered the possibility that intrinsic signals through CXCR3 
may prolong CD8+ T cell expression of CD25. To test this 
idea, CXCR3/ and WT OT-I cells were stimulated in vitro 
in the presence of CXCR3 ligands. As shown in Fig. 6 E, 
CXCR3 ligands had no impact on duration of CD25 ex-
pression on CD8+ T cells during the early expansion phase.   
This suggests that CXCR3/ CD8+ T cells are exposed to   
relatively weak inflammatory/antigenic stimuli in vivo, as 
Figure 7.  WT CD8+ T cells form clus-
ters in the MZ of spleen early in the 
expansion phase. Spleen sections of mice 
that received a 1:1 mixture of CD45.1+ 
CXCR3/ and CD90.1+ WT OT-I cells (1–3 ×  
106 cells total) and were infected with  
VV-OVA were analyzed by immunofluores-
cent staining. The splenic compartments are 
represented as follows: T, T cell zone; B,  
B cell zone; bold dashed line, WP–RP border; 
thin dashed line, T cell–B cell zone border. 
Bars, 50 µm. (A and B) Sections were stained 
for CD90.1 (red, WT OT-I), CD45.1 (green, 
CXCR3/ OT-I), and type IV collagen (blue). 
Arrows indicate clusters of WT OT-I cells.  
(B) Representative section from day 2 show-
ing distribution CXCR3/ and WT OT-I cells 
around T cell zone. (C) Ratio of OT-I cells in 
MZ/RP to those in WP. Data are shown as 
mean ± SEM. *, P < 0.01. (D) Sections were 
stained for CD11c (red), OT-I cells (green), 
and type IV collagen (blue) at day 2 after 
infection. (E) Sections were stained for 
CXCL9 (red), OT-I cells (green), and type IV 
collagen (blue) at day 2 after infection.  
(F) Sections were stained for IL-12p40 (red), 
OT-I cells (green), and type IV collagen (blue) 
at day 2 after infection. Data represent two 
(A–E) or three (F) independent experiments 
(n = 3–4 per time point).1614 CXCR3 and CD8+ T cell memory | Kurachi et al.
(Castellino et al., 2006; Semmling et al., 2010). Our study ex-
tends these ideas by showing that in the absence of surface 
expression of CXCR3, activated CD8+ T cells preferentially 
differentiate into MPECs and acquire longevity. We also found 
that CXCR3/ CD8+ T cells fail to cluster in MZ of spleen 
and exhibit shortened expression of CD25. These data suggest 
the novel idea that inflammatory chemokines have a substan-
tial impact on CD8+ T cell commitment to SLECs, rather than 
MPECs, by regulating localization of newly activated T cells 
within secondary lymphoid organs during early expansion.
Like the subcapsular sinus of lymph nodes, spleen MZ 
is an important site for capture of blood-borne pathogens 
and a gateway for lymphocytes entering the WP. The MZ is 
populated by B cells expressing high levels of surface IgM, 
DCs, and unique subsets of macrophages: ERTR-9–positive 
MZ macrophages and Moma-1–positive MZ metallophilic 
macrophages (Mebius and Kraal, 2005; Khanna and Lefrançois, 
2008). These MZ macrophage subsets are known to play 
a pivotal role in filtering pathogens (Seiler et al., 1997; 
Oehen et al., 2002; Aichele et al., 2003). Moreover, both 
populations of MZ macrophages are the main producers of 
type I IFNs as well as IL-12 and respond quickly after virus 
infection (Eloranta and Alm, 1999; Louten et al., 2006; Cui   
et al., 2009). Likewise, CXCL9 is predominantly produced 
by macrophages and DCs in the MZ (Rabin et al., 2003; Liu   
et al., 2005; Rosenblum et al., 2010). These subsequently ac-
celerate migration of conventional DCs to the T cell zone 
and cause aggregation of plasmacytoid DCs in the MZ, the 
latter of which further secrete type I IFNs (Barchet et al., 
2002; Asselin-Paturel et al., 2005; Mebius and Kraal, 2005). 
Consequently, these unique innate cell populations synergis-
tically enhance inflammatory milieu in the MZ. After entry 
of activated APCs to the WP, T cells are activated and up-
regulate CXCR3 (as shown in this study) and this may allow 
them to traffic to a highly inflamed MZ, where cells acquire 
additional inflammatory signals and differentiate into SLECs. 
Overall, MZ is crucial, not only for sampling and transporting 
blood-borne pathogens and antigens but also for supporting 
differentiation of effector CD8+ T cells by creating an in-
flammatory environment. In fact, MZ macrophages and MZ 
metallophilic macrophages can also be targets of LM and VV 
infection, respectively (Aichele et al., 2003; Muraille et al., 
2005; Junt et al., 2008), and provoke antigen presentation and 
inflammation in the MZ. These findings support our propo-
sitional model that CXCR3 plays a specific role in directing 
migration of newly activated CD8+ T cells to the MZ where 
they acquire further signals necessary to differentiation toward 
SLECs. In support of this idea, a recent paper has indicated 
that localization of antigen-experienced CD8+ T cells in the 
spleen is linked to their differentiation status by showing that 
CD127hi MPECs and memory cells are predominantly local-
ized in the T cell zone, whereas CD127lo SLECs and effector 
cells localize to the RP, which is closely connected to the MZ 
(Jung et al., 2010). Given the structural and cellular similarity of 
spleen and lymph node as T cell priming sites, it is interesting 
to examine whether CXCR3-mediated guidance influences 
zones in white pulp (WP) at 24 h after infection (Fig. 7 A).   
At 48 h, when high-level expression of CD25 remained on 
WT but not CXCR3/ CD8+ T cells (Fig. 6, A and C), WT 
CD8+ T cells formed significant clusters at the MZ, whereas 
CXCR3/ CD8+ T cells rarely formed clusters and mainly 
existed in the T cell zone (Fig. 7, A–C). As already established 
(Khanna et al., 2007), antigen-specific CD8+ T cells within 
the clusters were in close contact with CD11c+ DCs (Fig. 7 D). 
DC–T cell interactions were also observed in the T cell zone 
(Fig. 7 D). Because CD8+ T cells up-regulate CD25 while 
cells are undergoing brief serial contact with DCs, followed 
by stable DC–T cell interactions (Mempel et al., 2004), these 
data, together with those of Fig. 6 A, indicate that during   
T cell activation, WT cells have stable contact with DCs both 
at the clusters and T cell zone. CXCR3/ cells, in contrast, 
are in contact only in the T cell zone. Cluster formation is 
probably not a result of superior clonal expansion of WT 
cells because both WT and CXCR3/ cells divided equally 
at this time point (Fig. 6 B and unpublished data). Rather, the 
CXCR3 ligands CXCL9 and CXCL10 are mainly expressed 
in the MZ where CXCR3/ cells fail to accumulate (Fig. 7 E 
and Fig. S6 A). This suggests that cluster formation of WT 
cells depends on CXCR3-mediated migration. It is known 
that DCs and macrophages in the MZ significantly express 
type I IFNs and IL-12 soon after infection, and this results 
in a highly inflamed microenvironment (Eloranta and Alm, 
1999; Barchet et al., 2002; Louten et al., 2006; Kalies et al., 
2008; Cui et al., 2009). Consistent with previous results,   
IL-12p40 and IFN- were predominantly expressed in the 
MZ (Fig. 7 F; and Fig. S6, B and C). These findings provide 
strong support for the idea that migration of activated CD8+ 
T cells to the MZ results in additional inflammatory stimuli, 
leading to prolonged expression of CD25 and accelerated dif-
ferentiation toward SLECs. When cells underwent several di-
visions and down-regulated CCR7 (Fig. 6 B and Fig. S7 A), 
both WT and CXCR3/ CD8+ T cells were detected at the 
RP (Fig. 7, A and C). Together, these data show that CXCR3 
influences  the  effector  commitment  of  CD8+ T  cells  via 
modulation of local distribution of activated cells during the 
early expansion phase.
DISCUSSION
The chemokine system has an essential role in optimal T cell 
response by coordinating localization and interaction of   
T cells and other immune cells (Bromley et al., 2008). The es-
tablished view is that homeostatic chemokines, such as CCL19 
and CCL21 (ligands of CCR7), play key roles in directing 
migration of both naive T cells and mature DCs to the drain-
ing lymph nodes where the adaptive immune response is ini-
tiated. Inflammatory chemokines, in contrast, are known to 
recruit full-fledged effector and memory T cells to inflamed 
nonlymphoid tissues where the pathogen first invades. Re-
cent studies also show the role of inflammatory chemokines 
in priming CD8+ T cells in which inflammatory chemokines, 
such as CCR4 and CCR5 ligands, secreted by licensed DCs, 
attract naive CD8+ T cells to promote DC–T cell interactions JEM Vol. 208, No. 8 
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proximity to inflammatory cytokines in the early expansion 
phase  plays  a  dominant  role  in  our  experimental  models. 
However, additional antigen exposure (TCR signaling) is an-
other possible mechanism for the CXCR3-mediated fate de-
cision in different models (locations and phases). Indeed, the 
accompanying article in this issue by Kohlmeier et al. demon-
strates that additional antigen exposure at peripheral sites (the 
lungs) in the late effector phase of influenza infection has 
a significant impact on the CXCR3/ CD8+ T cell fate   
decision.  Collectively,  it  appears  that  multiple  mechanisms 
mediate CXCR3-mediated memory degeneration, such as 
inflammatory signals during early priming and additional 
antigen exposure during the late effector phase.
In terms of exposure to cytokines, one possible mecha-
nism for differential CD25 expression between CXCR3/ 
and WT CD8+ T cells is the availability of IL-2. Duration, but 
not  initiation,  of  CD25  expression  on  activated T  cells  is 
largely  dependent  on  IL-2  availability  (Kalia  et  al.,  2010;   
Pipkin et al., 2010). IL-2 is known to be secreted directionally 
at  the  immune  synapse,  thus  favoring  CD25-expressing   
T cells in close proximity to APCs in either an autocrine or 
paracrine manner (Huse et al., 2006). On this basis, because 
maximum CD8+ T cell production of IL-2 and cluster forma-
tion were observed at the same time point, CXCR3-mediated 
cluster formation may also enhance the impact of IL-2 on 
CD8+ T cell differentiation into SLECs (Fig. 7, A-C; and   
Fig.  S7  B). Together,  CXCR3-mediated  migration  to  the 
highly inflamed microcompartment may be important not 
only in acquiring additional inflammatory signaling but   
also in gathering activated T cells at the antigen-rich region 
where T cells receive additional autocrine and paracrine   
IL-2 signals.
Although  our  data  support  the  idea  that  CXCR3- 
mediated migration to the MZ is responsible for effector CD8+  
T cell differentiation toward SLECs, the intrinsic effect of 
signaling through CXCR3 on this process must also be con-
sidered. Previous studies have addressed the role of chemo-
kine receptors as a source of costimulatory and/or growth 
signals (Taub et al., 1996; Nanki and Lipsky, 2000; Real et al., 
2004). In the case of CXCR3, earlier studies have shown that 
CXCR3  ligands  stimulate T  cell  proliferation  in  vitro  in 
MLR (Whiting et al., 2004). In addition, it has been shown 
that CXCR3 stimulation induces activation of TCR signal-
ing molecules ZAP-70, LAT, and PLC- and these enhance 
T cell proliferation and chemotaxis (Dar and Knechtle, 2007; 
Newton et al., 2009). Moreover, signaling through CXCR3 
induces activation of mTORC1 (Schwarz et al., 2009), which 
has recently been shown to be involved in memory CD8+  
T cell differentiation (Araki et al., 2009; Pearce et al., 2009). 
These important observations may explain enhanced differ-
entiation of WT CD8+ T cells toward SLECs as compared 
with CXCR3/ CD8+ T cells. Nevertheless, the descriptions 
of CXCR3-mediated intrinsic signals given in these in vitro 
studies  do  not  match  our  current  findings.  For  example, 
CXCR3/ CD8+ T cells in our study underwent equiva-
lent  proliferation and thus formed effector populations of 
early commitment of effector CD8+ T cell fates in models of   
localized infection.
It  is  particularly  interesting  that  CXCR3-dependent 
migration of activated CD8+ T cells to MZ takes place with 
maintained expression of CCR7. CCR7 is necessary to re-
tention of T cells within the T cell zone, and down-regulation 
of both CCR7 and its ligands (CCL19 and CCL21) after in-
fection  causes  exclusion  of T  cells  from  splenic WP. This   
allows these cells to enter the blood and peripheral tissues 
(Mebius and Kraal, 2005; Mueller et al., 2007). Our data show 
the relatively slow down-regulation of CCR7 on activated 
CD8+ T cells and suggest that CCR7 may work as a temporal 
sequestrator, just as CD69 does in the lymph nodes. This 
maintains activated T cells within the WP while cells acquire 
signals essential to differentiation. A balance between expres-
sion levels of CXCR3 and CCR7 on activated CD8+ T cells 
is probably a key factor in migratory force and subsequent 
fate decision. Our findings that preferential localization of 
WT CD8+ T cells in the MZ occurs early after infection sug-
gest that migratory cues mediated by CXCR3 modulate or 
override CCR7 cues when cells express CXCR3 at high lev-
els. It should be noted that elevated expression of CXCR3 is 
exclusive to activated, but not naive, CD8+ T cells. This may 
help selective recruitment of newly activated, but not non-
cognate, T cells to the MZ to maximize usage of inflamma-
tory cytokines for optimal differentiation of effector CD8+  
T cells. Overall, these observations support a model that early 
CD8+ T cell response is regulated by sequential involvement 
of  chemokine  receptors,  such  as  CCR7  (before  priming; 
gathering DCs and naive T cell), CCR4 and CCR5 (at prim-
ing; increasing DC–T cell interaction), and CXCR3 (after 
priming; enhancing effector differentiation).
It is known that TCR signaling is a trigger for up-regulation 
of CD25 (Kalia et al., 2010). Thus, the differential kinetics 
of CD25 expression, between CXCR3/ and WT CD8+ 
T cells early after infection, may be the result of not only an 
inflammatory stimuli gradient present in each microcompart-
ment but also different amounts of antigen that T cells en-
counter in the context of MHC class I during priming. In the 
presence of high-dose antigen, antigen-specific CD8+ T cells 
rapidly lose motility, up-regulate activation molecules in-
cluding CD25, and undergo stable interactions with DCs   
(Henrickson et al., 2008). This may cause in situ visible cluster 
formation in the antigen-rich region. On the basis of this as-
sumption, shortened CD25 expression on CXCR3/ CD8+ 
T cells may be a result of reduced strength and duration of 
TCR signaling and associated with failure of cluster forma-
tion. However, the amount of antigen available in vivo and 
strength of TCR signaling have an impact on the extent of 
T cell expansion (Kaech et al., 2002). Using recombinant vac-
cinia virus strains that produced high or low quantities of an 
OVA epitope, for example, it has been shown that CD8+ T cell 
expansion after equivalent viral infections is proportional to 
epitope density (Wherry et al., 1999). Because CXCR3/ 
and WT  CD8+ T  cells  underwent  identical  expansion  in   
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we speculated that expression of CXCR3 on memory CD8+ 
T cells may not be closely linked to its expression during 
priming. When CD8+ T cells are primed in the absence of 
CXCR3, cells receive relatively weak inflammatory signals 
and are differentiated preferentially into MPECs. In the case 
of WT CD8+ T cells, nearly all activated CD8+ T cells express 
CXCR3 after priming, followed by heterologous expression 
of CXCR3 on memory CD8+ T cells: CXCR3hi with a stable 
phenotype and CXCR3lo with an activated phenotype (Fig. 1 
and Fig. 6 B; Hikono et al., 2007). CXCR3lo memory CD8+ 
cells have poor proliferative ability and, thus, decrease in num-
ber over time (Hikono et al., 2007). Taking these findings   
together,  it  is  reasonable  to  conclude  that  the  CXCR3lo 
memory CD8+ T cell population is derived from CXCR3hi 
(capable of receiving strong inflammatory signals upon priming) 
but not CXCR3lo effector cells, although the mechanism re-
sponsible for the down-regulation of CXCR3 is unclear. Ex-
pression of CXCR3 remains on a subset of memory CD8+  
T  cells  that  exhibit  a  stable  phenotype  (CD27hi  CD127hi 
CD43lo), which seemingly conflicts with our findings. Im-
portantly, however, migration of activated (CXCR3+) CD8+ 
T cells to the MZ is not exclusive (Fig. 7), suggesting that 
CXCR3+  (stable)  memory  CD8+ T  cells  may  be  derived 
from CXCR3+ effector CD8+ T cells that remain within the 
T cell zone during priming. In fact, using classifications of 
Hikono et al. (2007), memory CD8+ T cells generated in the 
absence of CXCR3 (primed only in the T cell zone) exhibit 
a highly stable phenotype (CD27hi CD127hi) compared with 
their WT counterparts (Fig. 3). Although this classification fits 
nicely with our findings, the precise mechanisms regulating 
the dynamic expression of CXCR3 on antigen-experienced 
CD8+ T cells, and the role of this mechanism in maintaining 
this T cell population, remains to be elucidated.
Overall, we conclude that CXCR3 is a key factor in in-
fluencing early programming of CD8+ T cell differentiation. 
Because CXCR3 is rapidly expressed on almost all activated 
T cells, our findings strongly suggest that blockade of CXCR3-
mediated relocalization of CD8+ T cells to the hot spot dur-
ing the early expansion phase is a promising approach for 
improving accumulation of fully functional antigen-specific 
memory CD8+ T cells.
MATERIALS AND METHODS
Mouse and BM chimera. We purchased C57BL/6 mice from SLC, B6.
SJL-Ptprca  Pep3/BoyJ  (CD45.1+)  and  B6.Pl-Thy1a/Cy  (CD90.1+)  mice 
from The  Jackson  Laboratory,  and  Rag2/  OT-I  mice  from Taconic. 
B6.Ccr5/  mice  have  been  previously  described  (Murai  et  al.,  2003). 
B6.Cxcr3/ mice were provided by C. Gerard (Children’s Hospital, Harvard 
Medical  School,  Boston,  MA;  Hancock  et  al.,  2000).  B6.Cxcr3/  and 
B6.Ccr5/ mice were crossed with Rag2/ OT-I mice to generate Rag2/ 
CXCR3/ OT-I and Rag2/ CCR5/ OT-I mice, respectively. All mice 
were between 6 and 10 wk of age at the start of experiments. To generate 
mixed BM chimeras, B6 (CD45.2+) mice were lethally irradiated (9 Gy) and 
subsequently injected i.v. with a total of 1 × 107 BM cells containing a mix-
ture of CXCR3/ (CD45.1+) and B6 (CD45.2+) in a 1:1 ratio. Mice were 
left at least 50 d before infection. All mice were used in accordance with the 
Animal Care Committee Guidelines of the Graduate School of Medicine, 
the University of Tokyo.
equivalent size as WT cells both in vivo and vitro, even in the 
absence of CXCR3-mediated co-stimulation. Importantly, in 
contrast to findings in vivo, when we stimulated CD8+ T cells 
with CXCR3 ligands in vitro, we did not find any differences 
between CXCR3/ and WT CD8+ T cells in terms of   
phenotype, cytokine production, and survival after transfer. 
These important differences suggest that the intrinsic effects of 
CXCR3 observed in previous studies may play only a minor 
role in the overall CD8+ T cell response in vivo. Thus, our in 
vivo data strongly support our proposed model that CXCR3-
mediated altered distribution, rather than CXCR3-mediated 
intrinsic signals, plays a key role in the predominant genera-
tion of SLECs.
Because increased naive T cell precursor frequency results 
in nonphysiological T cell differentiation (Marzo et al., 2005; 
Badovinac et al., 2007), the data presented in this paper, using 
the adoptive transfer approach, needs careful evaluation. Tim-
ing of cluster formation by adoptive transfer TCR Tg cells, for 
example, was slightly different from that of endogenous anti-
gen-specific CD8+ T cells. In the adoptive transfer approach 
(transfer 106 naive TCR Tg), peak cluster formation was 
evident 2 d after infection, followed by rapid scattering of   
Tg cells at the RP by day 5. This indicates egression of these 
cells from spleen. In contrast, Khanna et al. (2007) have shown 
that  endogenous  antigen-specific  CD8+ T  cell  clustering 
starts by day 2 and is still detectable at day 6. Although this 
may be a result of different kinetics with regard to CD8+  
T cell response to the particular pathogens used in these stud-
ies (VV versus LM), it may also be a result of increased pre-
cursor frequency accelerating CD8+  T cell response (Badovinac 
et al., 2007; Obar et al., 2008). Furthermore, reduced numbers 
of TCR Tg cells (104) resulted in delayed cluster formation 
as well as peak CD25 expression by WT Tg cells (unpublished 
data). And regardless of the number of Tg cells transferred, 
prolonged  expression  of  CD25  on WT,  compared  with 
CXCR3/ CD8+ T cells, is evident in all the experimental 
conditions determined and critical to the possibility of cells 
forming clusters (unpublished data). These results suggest that 
failure of CXCR3/ CD8+ T cells to form clusters is not 
caused by increased intraclonal competition with nonphysio-
logical number of WT cells. Moreover, predominant memory 
formation of CXCR3/ CD8+ T cells was also observed 
under noncompetitive conditions (adoptive transfer approach 
using separate recipients; Fig. S2, C and D) or physiological 
precursor frequency (mixed BM chimera approach; Fig. S2, 
E–G). This supports our contention that, despite altered ki-
netics, precursor frequency is of minor importance to fated 
effector populations of CXCR3/ and WT CD8+ T cells.
Because heterologous expression of CXCR3 is evident 
on the functionally distinct memory CD8+ T cell populations 
(Hikono et al., 2007), an important question raised by the 
current study is how the CXCR3-mediated fate decision 
during priming contributes to CXCR3 expression and to the 
functionality of memory CD8+ T cells during memory phase. 
Based  on  our  findings  regarding  the  kinetics  of  CXCR3   
expression on antigen-experienced CD8+ T cells (Fig. 1), JEM Vol. 208, No. 8 
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CD45.1, and CD45.2, and BrdU incorporation was examined using a BrdU 
Flow kit (BD). In some proliferation assay, cells were labeled with 5 µM 
CFSE (Invitrogen) before transfer (Kurachi et al., 2007).
In vitro–generated CTL and effect of CXCR3 ligands in vitro. BM-
derived DCs (BMDCs) were generated by culture of BM cells with GM-
CSF  and  IL-4  as  previously  described  (Badovinac  et  al.,  2005).  After 
purification by CD8 negative selection, naive splenic OT-I cells were co-
cultured in vitro with BMDC pulsed with OT-I peptide (labeled at 10 nM) 
in the presence or absence of 0.1, 1, 10, 100, or 1,000 ng/ml CXCL9, CXCL10, 
and CXCL11 (PeproTech). 10 U/ml of recombinant human IL-2 was added 
to the culture medium after day 2. In the other experiments, OT-I cells were 
initially stimulated by 1 µg/ml of plate-bound anti-CD3 and anti-CD28 anti-
bodies and cultured in the presence of CXCL9, CXCL10, and CXCL11. 
Proliferation, phenotype, and cytokine production were analyzed 3–7 d later.
Quantitative  RT-PCR. RNA was isolated from 5 × 105 OT-I cells 
sorted by an ARIA cell sorter (BD). cDNA was synthesized using a High 
Capacity  cDNA  Reverse Transcription  kit  (Applied  Biosystems).  Real-
time PCR was performed using an ABI 7500 instrument (Applied Bio-
systems)  and  Universal  primer  kit  (Roche),  and  relative  fold  differences 
were  calculated. All  expression  values  were  normalized  to  levels  of  the 
naive OT-I cells (WT or CXCR3/). Primers used were as follows: 
Prdm1  forward,  5-GGCTCCACTACCCTTATCCTG-3;  Prdm1  probe, 
5-GCTCACAG-3; Prdm1 reverse, 5-TTTGGGTTGCTTTCCGTTT-3;   
Gapdh  forward,  5-AGTATGACTCCACTCACGGCAA-3;  Gapdh 
probe, 5-AACGGCACAGTCAAGGCCGAGAAT-3; and Gapdh reverse, 
5-TCTCGCTCCTGGAAGATGGT-3.
Immunofluorescence staining. Spleens were harvested and immersed in 
OCT medium (Sakura) and frozen in liquid nitrogen. For cytokine detec-
tion, 2–4-mm slices of spleen were incubated in PBS with brefeldin A for 
6 h at 37°C before OCT immersion. 6-µm frozen sections were fixed in 
acetone, air dried, and stained with combinations of anti–CD45.1-FITC, 
anti–CD90.1-APC/biotin,  anti–B220-biotin,  anti-CXCL9,  anti-CXCL10, 
anti–IL-12p40,  anti–IFN-,  anti–CD11c-biotin,  anti–sheep  IgG–Alexa 
Fluor 488, anti–type IV collagen serum, anti–rabbit IgG–Alexa Fluor 555, 
anti–goat IgG–Alexa Fluor 555, and streptavidin–Alexa Fluor 488/647. Fluo-
rescent images were obtained by a laser microscope (IX-70; Olympus) with 
a digital camera (EMCCD; Hamamatsu Photonics) and FluoView software 
(Olympus) and a fluorescent microscope (BZ-9000; Keyence). Distribution 
indexes were calculated as the ratio of [cells in RP + MZ] to [cells in WP].
Statistical analysis. Statistical significance was determined by Student’s t test 
using Prism 5 (GraphPad Software). Significance was set as any p-value <0.05.
Online supplemental material. Fig. S1 shows a similar phenotype and 
distribution of donor CXCR3/ and WT OT-I cells at the time of adoptive 
transfer. Fig. S2 shows that dominance of memory CXCR3/ OT-I cells was 
confirmed until the very late memory phase in both dual and single transfer 
experiments and in mixed BM chimera experiment. Fig. S3 shows that CCR5 
deficiency does not effect generation of memory CD8+ T cells. Fig. S4 shows 
that an increased number of memory CD8+ T cells in intact CXCR3/ 
mice can provide enhanced protective immunity upon subsequent challenge. 
Fig. S5 shows that the surface expression of TCR and functional avidity of 
CXCR3/ OT-I cells were similar to that of WT OT-I cells. Fig. S6 shows 
that CXCL10 and IFN- were also predominantly expressed in the MZ.   
Fig. S7 shows the kinetics of CCR7 and CXCR3 expression and IL-2 produc-
tion by OT-I cells in the early expansion phase. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20102101/DC1.
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Virus, bacteria, and infection. Recombinant VV-OVA (Kedl et al., 2000) 
and LM-OVA (Pope et al., 2001) were obtained from P. Marrack (University 
of Colorado, Denver, CO) and H. Shen (University of Pennsylvania, Phila-
delphia, PA), respectively. Pathogens were propagated, titrated, and infected 
by intravenous injection to tail vein as previously described (Kedl et al., 2000; 
Pope  et  al.,  2001;  Kurachi  et  al.,  2007).  Unless  otherwise  described,  we   
infected mice with VV-OVA at 2 × 106 PFU and LM-OVA at 5 × 104  
CFU. For splenic LM-OVA titration, spleens were removed 3 d after high-
dose (1 × 106–107 CFU) LM-OVA challenge, and 10-fold serial dilu-
tions of homogenized spleen were cultured on brain-heart-infusion plates   
containing erythromycin.
Adoptive transfer and isolation of lymphocytes. For adoptive transfer 
of naive cells, CD8+ T cells were isolated from spleen of naive CXCR3/ 
or WT OT-I mice by CD8 negative selection (Miltenyi Biotec). The indi-
cated number (1 × 104–106) of 1:1 mixed, or single OT-I cells, were trans-
ferred into nonirradiated naive recipient mice. After infection with VV-OVA 
or LM-OVA, major lymphoid and nonlymphoid organs were removed on 
the days indicated, and single cell suspensions were prepared as previously 
described (Kurachi et al., 2007). Unless otherwise stated in the relevant figure 
legends, all data in the manuscript is based on experiments conducted with 
spleen cells alone. RBCs in the cell suspensions were lysed using ammonium 
chloride. To transfer memory OT-I cells, CXCR3/ and WT memory OT-I 
cell were generated in the two groups of mice. Spleen cells containing OT-I 
cells were isolated and further enriched for CD8+ cells using CD8 negative 
selection. Before transfer, CD8+ enriched spleen cells were analyzed to deter-
mine the proportion of CXCR3/ or WT OT-I cells and were mixed care-
fully such that the cell mixture contained equal numbers of CXCR3/ and 
WT OT-I cells or were transferred separately such that each recipient mouse 
received an equal number of OT-I cells (1.9–2 × 106 cells).
Reagents, antibodies, and flow cytometry analysis. Recombinant IL-2, 
IL-4, GM-CSF, CXCL9, CXCL10, and CXCL11 were purchased from 
PeproTech. MHC class I peptide tetramers were purchased from MBL. OT-I 
epitope  peptides  (OVA257-264:  SIINFEKL)  were  obtained  from  Sigma-
  Aldrich. CpG ODN 1826 was purchased from Invitrogen. All antibodies 
used were purchased from BioLegend except for CD8a, KLRG1, IL-2, and 
CD43 (1B11; BD), CCR7 (eBioscience), anti–human granzyme B (GB12) 
and streptavidin–Alexa Fluor 488/647 (Invitrogen), anti-CXCL9 (R&D Sys-
tems),  anti-CXCL10  (Santa  Cruz  Biotechnology,  Inc.),  and  anti–IFN- 
(Hycult Biotech). Assessment of caspase activity and DNA fragmentation was 
performed using FLICA Poly Caspases Assay kit (Immunochemistry Tech-
nologies) and APO-BrdU TUNEL Assay kit (Invitrogen). For intracellular 
cytokine staining, single cell suspension was incubated with or without 1 µM 
OT-I peptide in the presence of brefeldin A and IL-2 for 5 h at 37°C and 
stained using the Cytofix/Cytoperm kit (BD). Samples were analyzed on an 
LSRII (BD) and data were analyzed with FlowJo software (Tree Star).
In vivo CTL assay. The indicated number of CXCR3/ and WT mem-
ory OT-I cells separately generated were adoptively transferred into naive 
CD45.1+ mice. On the next day, a mixture of 5 × 106 unpulsed spleen cells 
labeled with 1 µM CFSE and 5 × 106 spleen cells pulsed with 1 µM OT-I 
peptide and labeled with 5 µM CFSE was administered intravenously to the 
indicated groups as well as a control group that received no memory cells. 
4 h later, spleens were harvested, and the percentages of CFSE+ cells that 
were CFSEhi and CFSElo was assessed by flow cytometer. The percent specific   
killing was calculated as: 100  (100 × [(%CFSElo/%CFSEhi)/(%CFSElo in 
no memory cells group/%CFSEhi in no memory cells group)].
Measurement of proliferation by BrdU incorporation and CFSE. 
Mice were administered BrdU (200 µl of a 4 mg/ml solution in PBS) i.p. For 
assessment of acute proliferation in effector phase, mice were sacrificed 24 h 
after BrdU injection. For assessment of homeostatic proliferation in memory 
phase, mice were maintained on drinking water containing 0.8 mg/ml BrdU 
for 17 d. Single cell suspensions were stained with Abs to CD8a, TCR V2, 1618 CXCR3 and CD8+ T cell memory | Kurachi et al.
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